Becton, Dickinson and Company (BD) has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush prefilled flush syringes at its facility in Columbus, Nebraska, US. This ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...

Becton, Dickinson and Co. plans to invest more than $35 million to expand a prefilled flush syringe manufacturing facility in Nebraska to better meet growing demand from U.S. hospitals and health care ...

The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe. Becton, Dickinson and Company (BD) ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX), said Wednesday it plans to invest about $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity as ...

Becton, Dickinson and Company (BD) and Ypsomed have announced an expansion of their partnership with the development of a 5.5ml version of the BD Neopak XtraFlow glass prefillable syringe. The new ...

BD has positioned itself to unlock a new COVID-19 vaccine opportunity by showing its glass prefilled syringes are suitable for use with mRNA shots that need storing at ultralow temperatures. As the ...